Developed by Lazarex Cancer Foundation, the IMPACT programme combines financial reimbursement and outreach to help cancer patients learn about and access advanced treatment in clinical trials.

IMPACT is aimed at creating equal access to clinical trials for all patients and will educate patients about clinical trials as an opportunity for treatment of advanced cancers.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

IMPACT involves a partnership between Lazarex Cancer Foundation, Amgen–the Founding IMPACT Sponsor, UCSF Helen Diller Comprehensive Cancer Center and USC Norris.

Lazarex Cancer Foundation founder Dana Dornsife said: “By offering reimbursements through IMPACT, patients can say ‘yes’ to participating in clinical trials.

“Consequently, clinical trials see increased patient enrollment, minority participation, and patients are better able to stay the course of the trial.”

The IMPACT programme will also be studied as a non-therapeutic interventional trial focused on educating cancer patients about clinical trials.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Additionally, IMPACT coordinates NeighborGood, a community outreach effort, with other community organisations, advisors and health clinics to raise awareness on topics such as prevention, early diagnosis through screenings, clinical trial education, among others to improve patient health outcomes.

IMPACT principal investigator Darcy Spicer said: “We are hopeful that this study provides more people with access to burgeoning clinical innovations while informing the scientific community about the most effective means to treat cancer.”

In a pilot programme carried out at Massachusetts General Hospital for three years, IMPACT improved patient enrollment by 29% and doubled minority participation.